AiCure

New York, United States Founded: 2010 • Age: 16 yrs
Medication adherence is visually confirmed via AI platform.
Request Access

About AiCure

AiCure is a company based in New York (United States) founded in 2010 by Gordon Kessler.. AiCure has raised $55.75 million across 11 funding rounds from investors including SVB, New Leaf Venture Partners and HHS. The company has 16 employees as of December 31, 2022. AiCure offers products and services including H.Code, eCOA - ePRO, and Adherence and Dosing. AiCure operates in a competitive market with competitors including Wellth, Cureatr, Phil, Capsa Healthcare and Spencer Health Solutions, among others.

  • Headquarter New York, United States
  • Employees 16 as on 31 Dec, 2022
  • Founders Gordon Kessler
  • Sectors
    Healthcare
    Technology
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Technology → Artificial Intelligence & Machine Learning
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $55.75 M (USD)

    in 11 rounds

  • Latest Funding Round
    $12 M (USD), Debt – Conventional

    Jan 23, 2024

  • Investors
    SVB

    & 13 more

  • Employee Count
    16

    as on Dec 31, 2022

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of AiCure

AiCure offers a comprehensive portfolio of products and services, including H.Code, eCOA - ePRO, and Adherence and Dosing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

AI tool for monitoring and assisting clinical trial participants.

Captures participant responses to support trial data collection.

Tracks participant adherence to prevent trial dropouts.

People of AiCure
Headcount 50-200
Employee Profiles 17
Employee Profiles
People
Irene Mantikas
Senior Project Manager
People
Haiyan Wei
Senior Vice President, Technology And Operations
People
Megan Gross
Director, Project Delivery & Research (head)
People
Alexis Jennings
Manager, Contracts

Unlock access to complete

Funding Insights of AiCure

AiCure has successfully raised a total of $55.75M across 11 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $12 million completed in January 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 11
  • Last Round Debt – Conventional — $12.0M
  • First Round

    (05 Sep 2011)

  • Investors Count 14
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2024 Amount Series C - AiCure Valuation

investors

Jan, 2024 Amount Debt – Conventional - AiCure Valuation

investors

Nov, 2019 Amount Series C - AiCure Valuation Palisades Growth Capital
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in AiCure

AiCure has secured backing from 14 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, New Leaf Venture Partners and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Tech & Life-Sciences focused Stage-agnostic VC firm investing in geographies such as North America
Founded Year Domain Location
Venture capital investments are backed by Singtel through Innov8.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by AiCure

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - AiCure

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aicure Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of AiCure

AiCure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wellth, Cureatr, Phil, Capsa Healthcare and Spencer Health Solutions, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provides AI and cloud-based platform for doctors for patient engagement and care
domain founded_year HQ Location
Cloud-based medication management software is provided for healthcare providers.
domain founded_year HQ Location
Prescription drugs refill management solutions
domain founded_year HQ Location
Medication management systems are supplied to healthcare providers and pharmacies.
domain founded_year HQ Location
Devices and apps for medication adherence are provided.
domain founded_year HQ Location
Cloud-based medication adherence monitoring is provided for healthcare providers.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aicure

Frequently Asked Questions about AiCure

When was AiCure founded?

AiCure was founded in 2010 and raised its 1st funding round 1 year after it was founded.

Where is AiCure located?

AiCure is headquartered in New York, United States. It is registered at New York, New York, United States.

Who is the current CEO of AiCure?

Edward Ikeguchi is the current CEO of AiCure.

Is AiCure a funded company?

AiCure is a funded company, having raised a total of $55.75M across 11 funding rounds to date. The company's 1st funding round was a Series C of $24.5M, raised on Sep 05, 2011.

How many employees does AiCure have?

As of Dec 31, 2022, the latest employee count at AiCure is 16.

What does AiCure do?

AiCure was established in 2010 in New York, United States, as a SaaS provider in the health technology sector. An AI-based platform is utilized to monitor medication adherence through visual verification in clinical trials and routine care settings. Machine learning, computer vision, and big data are applied via mobile devices, with patented facial recognition and motion-sensing features employed to observe patient actions during medication intake.

Who are the top competitors of AiCure?

AiCure's top competitors include Wellth, Phil and Capsa Healthcare.

What products or services does AiCure offer?

AiCure offers H.Code, eCOA - ePRO, and Adherence and Dosing.

Who are AiCure's investors?

AiCure has 14 investors. Key investors include SVB, New Leaf Venture Partners, HHS, Singtel Innov8, and Palisades Growth Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available